Bath & Body Works, Inc. $BBWI Shares Purchased by 1834 Investment Advisors Co.

Key Points

• 1834 Investment Advisors increased its Bath & Body Works stake by 63.8% in the third quarter, holding 316,246 shares worth approximately $5.0 million. Institutional investors collectively own 95.14% of the company.
• Bath & Body Works reported quarterly EPS of $0.62, exceeding estimates of $0.24, while revenue reached $1.51 billion but declined 2.3% year over year. The company issued fiscal 2026 EPS guidance of $2.60–$2.80.
• The stock was trading at $20.17, while analysts maintained a consensus “Hold” rating and an average price target of $22.13. The company also pays a quarterly dividend of $0.20 per share, representing a 4.0% annualized yield.

1834 Investment Advisors Co. boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 63.8% in the third quarter, according to its most recent filing with the SEC. The firm owned 316,246 shares of the company's stock after acquiring an additional 123,222 shares during the period. 1834 Investment Advisors Co. owned 0.16% of Bath & Body Works worth $5,035,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Elevation Wealth Partners LLC increased its holdings in Bath & Body Works by 5,278.8% in the second quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company's stock valued at $41,000 after purchasing an additional 1,742 shares during the last quarter. MidFirst Bank acquired a new position in Bath & Body Works in the fourth quarter valued at about $51,000. Parallel Advisors LLC lifted its stake in Bath & Body Works by 35.5% in the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company's stock valued at $48,000 after buying an additional 673 shares during the period. Meeder Asset Management Inc. bought a new position in Bath & Body Works during the second quarter worth about $66,000. Finally, Global Retirement Partners LLC bought a new position in Bath & Body Works during the second quarter worth about $71,000. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 1.3%

NYSE:BBWI opened at $20.17 on Friday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $27.40. The stock has a 50-day moving average price of $18.13 and a two-hundred day moving average price of $19.06. The stock has a market cap of $4.07 billion, a price-to-earnings ratio of 5.25, a PEG ratio of 1.01 and a beta of 1.40.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.38. The company had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. Bath & Body Works's revenue was down 2.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Sell-side analysts forecast that Bath & Body Works, Inc. will post 2.73 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Stockholders of record on Friday, August 21st were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, August 21st. This represents a $0.80 annualized dividend and a dividend yield of 4.0%. Bath & Body Works's dividend payout ratio is currently 20.83%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft set a $22.00 target price on Bath & Body Works in a research report on Thursday, August 27th. Robert W. Baird cut their price target on shares of Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating on the stock in a research report on Thursday, August 27th. Morgan Stanley cut their price target on shares of Bath & Body Works from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 27th. Argus reissued a "hold" rating on shares of Bath & Body Works in a research note on Wednesday, September 16th. Finally, Jefferies Financial Group boosted their price objective on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a "hold" rating in a report on Tuesday, July 28th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $22.13.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its portfolio includes body lotions and creams, shower products, fragrances, hand soaps and sanitizers, three-wick candles, wall-plug air fresheners, and other home-fragrance items. The company markets products under the Bath & Body Works brand and regularly introduces seasonal and limited-edition collections.

The company sells its products through a network of company-operated stores, its e-commerce website, and other direct channels.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.